IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bristol-Myers Squibb Co

CUSIP: 110122109 | 2 institutional holders

Quarters

Q2 2023Q2 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Ascentis Independent Advisors10,074
0.2% of portfolio›$644.2K
StyleTurnoverLocationFiled
Ascentis Independent Advisors
10,074$644.2K0.2%GrowthLowDallas, TX2023-07-19